Bruce Montgomery is the founder of Avalyn Pharma. Avalyn Pharma has raised $211M in total funding. Latest round: Series B. Based in Seattle, United States.
Bruce Montgomery, M.D., is the founder and CEO of Avalyn Pharma, a clinical-stage biopharmaceutical company developing inhaled therapies for rare respiratory diseases. He has led the company through multiple funding rounds, including a $35.5 million Series B in 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library